ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,557.78
      0.96%
      US Tech 100
      19,243.60
      1.23%
      Dow Jones
      40,397.06
      0.27%
      Brent Oil
      81.565
      -0.87%
      Bitcoin
      67,104.74
      -1.54%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Inovio Pharmaceuticals Inc New (INO)

      7. Inovio Pharmaceuticals Inc New (INO) Financials

      Inovio Pharmaceuticals Inc New

      Inovio Pharmaceuticals Inc New (INO)

      Inseego Corp
      10.33
      0.26
      ( 2.58% )
      Updated: 12:51:12
      Delayed by 15 minutes

      Inovio Pharmaceuticals Inc New Financial Summary

      The current INO market cap is 267.66M. The company's latest EPS is USD -5.2147 and P/E is -1.98.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 115k226k388k103k0
      Operating Income -43.34M-36.88M-35.34M-27.61M-31.61M
      Net Income -40.65M-35.53M-33.93M-25M-30.47M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 4.11M7.41M1.78M10.26M832k
      Operating Income -114.2M-87.53M-301.77M-269.47M-143.17M
      Net Income -119.36M-166.41M-303.66M-279.82M-135.12M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 266.58M233.04M193.1M170.95M129.11M
      Total Liabilities 67.37M63.67M54.94M53.6M34.67M
      Total Equity 199.21M169.37M138.16M117.35M94.44M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 143.95M539.77M495.94M348.53M170.95M
      Total Liabilities 138.55M78.63M96.27M126.17M53.6M
      Total Equity 5.41M461.14M399.67M222.36M117.35M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -36.66M-68.98M-98.09M-124.37M-28.76M
      Investing 19M72.91M67.41M87.36M45.38M
      Financing -425k2.46M3.16M5M-11.36M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -97.85M-177.98M-215.71M-216.22M-124.37M
      Investing -9.05M-58.8M-175.34M109.59M87.36M
      Financing 105.4M465.28M211.5M81.84M5M

      Stats and Ratios

      Market Cap 267.66M
      Price to Earnings Ratio -1.98
      Price to Sales Ratio 322.12
      Price to Cash Ratio 18.72
      Price to Book Ratio 2.28
      Dividend Yield -

      Share Statistics

      Shares Outstanding 25.91M
      Average Volume (1 week) 389.7k
      Average Volume (1 Month) 388.02k
      52 Week Change 62.57%
      52 Week High 14.748
      52 Week Low 3.888
      Spread (Intraday) 0.04 (0.39%)

      Company Info

      Company Name Inovio Pharmaceuticals Inc New
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.inovio.com
      Industry surgical,med instr,apparatus (3841)